Literature DB >> 21872452

Neural correlates of sleepiness induced by catecholamine depletion.

Noah Meyers1, Stephen Fromm, David A Luckenbaugh, Wayne C Drevets, Gregor Hasler.   

Abstract

Although extensive indirect evidence exists to suggest that the central dopaminergic system plays a significant role in the modulation of arousal, the functional effect of the dopaminergic influence on the regulation of the sleep-wake cycle remains unclear. Thirteen healthy volunteers and 15 unmedicated subjects with a history of major depressive disorder underwent catecholamine depletion (CD) using oral alpha-methyl-para-tyrosine in a randomized, placebo-controlled, double-blind, crossover study. The main outcome measures in both sessions were sleepiness (Stanford-Sleepiness-Scale), cerebral glucose metabolism (positron emission tomography), and serum prolactin concentration. CD consistently induced clinically relevant sleepiness in both groups. The CD-induced prolactin increase significantly correlated with CD-induced sleepiness but not with CD-induced mood and anxiety symptoms. CD-induced sleepiness correlated with CD-induced increases in metabolism in the medial and orbital frontal cortex, bilateral superior temporal cortex, left insula, cingulate motor area and in the vicinity of the periaqueductal gray. This study suggests that the association between dopamine depletion and sleepiness is independent of the brain reward system and the risk for depression. The visceromotor system, the cingulate motor area, the periaqueductal gray and the caudal hypothalamus may mediate the impact of the dopaminergic system on regulation of wakefulness and sleep. Published by Elsevier Ireland Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21872452      PMCID: PMC3185157          DOI: 10.1016/j.pscychresns.2011.06.015

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  51 in total

1.  Imaging D2 receptor occupancy by endogenous dopamine in humans.

Authors:  M Laruelle; C D D'Souza; R M Baldwin; A Abi-Dargham; S J Kanes; C L Fingado; J P Seibyl; S S Zoghbi; M B Bowers; P Jatlow; D S Charney; R B Innis
Journal:  Neuropsychopharmacology       Date:  1997-09       Impact factor: 7.853

2.  TYROSINE HYDROXYLASE. THE INITIAL STEP IN NOREPINEPHRINE BIOSYNTHESIS.

Authors:  T NAGATSU; M LEVITT; S UDENFRIEND
Journal:  J Biol Chem       Date:  1964-09       Impact factor: 5.157

3.  Neurons in the rostral cingulate motor area monitor multiple phases of visuomotor behavior with modest parametric selectivity.

Authors:  Eiji Hoshi; Hiromasa Sawamura; Jun Tanji
Journal:  J Neurophysiol       Date:  2005-02-09       Impact factor: 2.714

4.  Identification of wake-active dopaminergic neurons in the ventral periaqueductal gray matter.

Authors:  Jun Lu; Thomas C Jhou; Clifford B Saper
Journal:  J Neurosci       Date:  2006-01-04       Impact factor: 6.167

5.  Excessive daytime sleepiness in young adults: a 20-year prospective community study.

Authors:  Gregor Hasler; Daniel J Buysse; Alex Gamma; Vladeta Ajdacic; Dominique Eich; Wulf Rössler; Jules Angst
Journal:  J Clin Psychiatry       Date:  2005-04       Impact factor: 4.384

6.  Effect of alpha-methyl-para-tyrosine on response to cocaine challenge.

Authors:  S M Stine; J H Krystal; I L Petrakis; P I Jatlow; G R Heninger; T R Kosten; D S Charney
Journal:  Biol Psychiatry       Date:  1997-08-01       Impact factor: 13.382

7.  Dopaminergic modulation of arousal in Drosophila.

Authors:  Rozi Andretic; Bruno van Swinderen; Ralph J Greenspan
Journal:  Curr Biol       Date:  2005-07-12       Impact factor: 10.834

8.  Transient depressive relapse induced by catecholamine depletion: potential phenotypic vulnerability marker?

Authors:  R M Berman; M Narasimhan; H L Miller; A Anand; A Cappiello; D A Oren; G R Heninger; D S Charney
Journal:  Arch Gen Psychiatry       Date:  1999-05

Review 9.  What keeps us awake: the neuropharmacology of stimulants and wakefulness-promoting medications.

Authors:  Benjamin Boutrel; George F Koob
Journal:  Sleep       Date:  2004-09-15       Impact factor: 5.849

10.  Neurotoxic N-methyl-D-aspartate lesion of the ventral midbrain and mesopontine junction alters sleep-wake organization.

Authors:  Y Y Lai; T Shalita; T Hajnik; J P Wu; J S Kuo; L G Chia; J M Siegel
Journal:  Neuroscience       Date:  1999-05       Impact factor: 3.590

View more
  5 in total

1.  Neural correlates of free T3 alteration after catecholamine depletion in subjects with remitted major depressive disorder and in controls.

Authors:  Philipp Homan; Wayne C Drevets; Gregor Hasler
Journal:  Psychopharmacology (Berl)       Date:  2013-08-18       Impact factor: 4.530

2.  Altered slow wave activity in major depressive disorder with hypersomnia: a high density EEG pilot study.

Authors:  David T Plante; Eric C Landsness; Michael J Peterson; Michael R Goldstein; Tim Wanger; Jeff J Guokas; Giulio Tononi; Ruth M Benca
Journal:  Psychiatry Res       Date:  2012-04-16       Impact factor: 3.222

3.  Catechol-O-methyltransferase gene val158met polymorphism and depressive symptoms during early childhood.

Authors:  Haroon I Sheikh; Katie R Kryski; Heather J Smith; Lea R Dougherty; Daniel N Klein; Sara J Bufferd; Shiva M Singh; Elizabeth P Hayden
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2013-03-08       Impact factor: 3.568

Review 4.  The comorbidity of insomnia, chronic pain, and depression: dopamine as a putative mechanism.

Authors:  Patrick H Finan; Michael T Smith
Journal:  Sleep Med Rev       Date:  2012-06-29       Impact factor: 11.609

5.  REM sleep deprivation reverses neurochemical and other depressive-like alterations induced by olfactory bulbectomy.

Authors:  Maira J Maturana; Cláudia Pudell; Adriano D S Targa; Laís S Rodrigues; Ana Carolina D Noseda; Mariana H Fortes; Patrícia Dos Santos; Cláudio Da Cunha; Sílvio M Zanata; Anete C Ferraz; Marcelo M S Lima
Journal:  Mol Neurobiol       Date:  2014-05-15       Impact factor: 5.590

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.